Multi-institutional study of peritoneal sarcomatosis from uterine sarcoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
01 Pubblicazione su rivista
Sardi Armando, Sipok Arkadii, Baratti Dario, Deraco Marcello, Sugarbaker Paul, Salti George, Yonemura Yutaka, Sammartino Paolo, Glehen Olivier, Bakrin Naoual, Díaz-Montes Teresa P., Gushchin Vadim
ISSN: 0748-7983
Objective Uterine sarcoma (US) is a rare tumor representing 1% of female genital tract malignancies. Peritoneal sarcomatosis (PS) after US, diminishes median overall survival (OS) and progression-free survival (PFS) with cytoreductive surgery (CRS) alone, with or without systemic chemotherapy is